Impairment of the protein C anticoagulation pathway is critical to the thrombosis associated with sepsis and to the development of purpura fulminans in meningococcemia. We studied the expression ...

Doherty JU, Gluckman TJ, Hucker WJ, et al. 2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation. J Am Coll ...

UK national guidelines recommend rapid reversal of anticoagulation using prothrombin ... they analyzed the treatment pathway for 26 patients with ICH receiving OAT by retrospectively reviewing ...

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients. ... Tecarfarin, with its novel metabolic pathway, ...

Coagulation factor Xa is targeted by a new generation of antithrombotic drugs such as rivaroxaban. However, as excessive factor Xa inhibition can cause bleeding, the clinical use of factor Xa ...

There have been numerous advances in the field of anticoagulation over the last two decades, ... rivaroxaban), soluble thrombomodulin, and tissue pathway factor inhibitor. ...

The pathway, which applies to both vitamin K antagonists and non-vitamin K antagonist oral anticoagulants (NOACs), takes clinicians from the assessment of bleed severity to acute medical and surgical ...

A new document for the management of patients with irregular heartbeats who are on anticoagulation medications--blood thinners--and need surgery, focuses on how and when to temporarily stop these ...

(HealthDay)—A decision pathway has been developed to guide management of acute bleeding in patients treated with oral anticoagulants (OACs); the decision pathway was published online Dec. 1 in ...

A new document for the management of patients with irregular heartbeats who are on anticoagulation medications—blood thinners—and need surgery, focuses on how and when to temporarily stop ...